Search Results - "Claassen, Daniel"

β-Blocker effects in huntington's disease: A caution on clinical interpretation.

Authors: Aziz, N Ahmad Claassen, Daniel Petersén, Åsa et al.

Source: Journal of Huntington's Disease. Feb2026, Vol. 15 Issue 1, p179-180. 2p.

Correction: Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD.

Authors: Stimming, Erin Furr Claassen, Daniel O. Sen, Ginny P. et al.

Source: Neurology & Therapy. Jun2025, Vol. 14 Issue 3, p757-758. 2p.

The Association of Quality of Life with Psychosocial Factors in Adolescents with Tourette Syndrome.

Authors: Watson, Kelly H. Eckland, Michelle Schwartzman, Jessica M. et al.

Source: Child Psychiatry & Human Development. Dec2025, Vol. 56 Issue 6, p1586-1597. 12p.

Subjects: Quality of life, Family relations, Teenagers, Self-esteem, Psychological stress, Psychosocial factors, Tourette syndrome, Internalizing behavior

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.

Authors: Frank, Samuel Anderson, Karen E. Fernandez, Hubert H. et al.

Source: Neurology & Therapy. Dec2024, Vol. 13 Issue 6, p1747-1749. 3p.

Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia.

Authors: Gibbons, Christopher H. Levine, Todd Adler, Charles H. et al.

Source: Annals of Clinical & Translational Neurology. May2026, Vol. 13 Issue 5, p1041-1051. 11p.

The Role of a Dopamine-Dependent Limbic–Motor Network in Sensory Motor Processing in Parkinson Disease.

Authors: Mann, Leah G. Servant, Mathieu Hay, Kaitlyn R. et al.

Source: Journal of Cognitive Neuroscience. Nov2023, Vol. 35 Issue 11, p1806-1822. 17p.

Subjects: Parkinson's disease, Sensorimotor integration, Globus pallidus, Control (Psychology), Positron emission tomography

The parasagittal dural space of the human brain.

Authors: Donahue, Manus J McKnight, Colin D Claassen, Daniel O et al.

Source: Brain: A Journal of Neurology; Oct2025, Vol. 148 Issue 10, p3481-3495, 15p

Associations Between Lifetime Stressor Exposure and Externalizing Problems in Youth at Risk for Huntington Disease.

Authors: McDonell, Katherine E. Shiino, Shuhei Key, Elizabeth M. et al.

Source: Brain & Behavior. Apr2026, Vol. 16 Issue 4, p1-11. 11p.

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis.

Authors: Claassen, Daniel O. Ayyagari, Rajeev Garcia-Horton, Viviana et al.

Source: Neurology & Therapy. Mar2022, Vol. 11 Issue 1, p435-448. 14p.

Mesial temporal dopamine: From biology to behaviour.

Authors: Mann, Leah G. Claassen, Daniel O.

Source: European Journal of Neuroscience. Mar2024, Vol. 59 Issue 6, p1141-1152. 12p.

Subjects: Dopaminergic neurons, Dopamine, Biology, Parkinson's disease, Temporal lobe, Substantia nigra

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy.

Authors: Trujillo, Paula Hett, Kilian Cooper, Amy et al.

Source: Annals of Clinical & Translational Neurology. Sep2025, Vol. 12 Issue 9, p1823-1833. 11p.

Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function.

Authors: Trujillo, Paula Aumann, Megan A Claassen, Daniel O

Source: Brain: A Journal of Neurology; Feb2024, Vol. 147 Issue 2, p337-351, 15p

Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study.

Authors: Jankovic, Joseph Coffey, Barbara Claassen, Daniel O. et al.

Source: Movement Disorders Clinical Practice. Sep2023, Vol. 10 Issue 9, p1388-1398. 11p.

Behavioral Effects of Stimulated Dopamine Release and D2-like Receptor Displacement in Parkinson's Patients with Impulse-Control Disorder.

Authors: Aumann, Megan A. Lee, Sean J. Song, Alexander K. et al.

Source: International Journal of Molecular Sciences. Apr2025, Vol. 26 Issue 8, p3866. 16p.

Corticostriatal beta oscillation changes associated with cognitive function in Parkinson's disease.

Authors: Paulo, Danika L Qian, Helen Subramanian, Deeptha et al.

Source: Brain: A Journal of Neurology; Sep2023, Vol. 146 Issue 9, p3662-3675, 14p

Deciphering Cognitive Impairments in Huntington's Disease: A Comparative Study of Stroop Test Variations.

Authors: Sierra, Luis A. Wynn, Amy Lanzaro, Ella et al.

Source: Journal of Huntington's Disease. 2024, Vol. 13 Issue 2, p249-257. 9p.

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease.

Authors: Kumar, Rajeev Agarwal, Pinky Anderson, Karen et al.

Source: Movement Disorders. Mar2026, p1. 10p. 3 Illustrations.

Understanding speech and swallowing difficulties in individuals with Huntington disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks.

Authors: Carlozzi, Noelle E. Boileau, Nicholas R. Roberts, Angela et al.

Source: Quality of Life Research. 2021, Vol. 30 Issue 1, p251-265. 15p. 6 Charts, 3 Graphs.

Subjects: Huntington disease, Patient reported outcome measures, Deglutition, Speech apraxia, Cronbach's alpha, Quality of life

Amphetamine-induced dopamine release and impulsivity in Parkinson's disease.

Authors: Song, Alexander K Hay, Kaitlyn R Trujillo, Paula et al.

Source: Brain: A Journal of Neurology; Oct2022, Vol. 145 Issue 10, p3488-3499, 12p

Abstracts of the 1st Biennial Huntington's Disease Clinical Research Congress, October 11-13, 2025, Nashville, TN.

Source: Journal of Huntington's Disease. 2025 Suppl 1, Vol. 14, pS1-S50. 50p.